Cleviprex (Fresenius Kabi Austria GmbH)
Welcome to the PulseAid listing for the Cleviprex drug offered from Fresenius Kabi Austria GmbH. This Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Fresenius Kabi Austria GmbH |
| NON-PROPRIETARY NAME: | clevidipine |
| SUBSTANCE NAME: | CLEVIDIPINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | EMULSION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2008-09-15 |
| END MARKETING DATE: | 0000-00-00 |
Cleviprex HUMAN PRESCRIPTION DRUG Details:
| Item Description | Cleviprex from Fresenius Kabi Austria GmbH |
| LABELER NAME: | Fresenius Kabi Austria GmbH |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.5(mg/mL) |
| START MARKETING DATE: | 2008-09-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 18124-011_a6826aa3-fabb-4ff1-a7a3-cd4c34e3a330 |
| PRODUCT NDC: | 18124-011 |
| APPLICATION NUMBER: | NDA022156 |
Other CLEVIDIPINE Pharmaceutical Manufacturers / Labelers:
